Emily A. Schonfeld

Genetic Causes of Liver Disease: When to Suspect a Genetic Etiology, Initial Lab Testing, and the Basics of Management.

Robert S. Brown, Emily A. Schonfeld, 2019, The Medical clinics of North America.

Genetic Testing in Liver Disease: What to Order, in Whom, and When.

Robert S. Brown, Emily A. Schonfeld, 2017, Clinics in liver disease.

Costs of telaprevir‐based triple therapy for hepatitis C: $189,000 per sustained virological response

A. Branch, V. Martel-Laferrière, A. Moskowitz, 2014, Hepatology.

Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice‐based recommendations

D. Dadhania, S. Hall, M. Kriss, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir‐based triple therapy

A. Branch, V. Martel-Laferrière, D. Dieterich, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors.

H. Varmus, W. Pao, K. Politi, 2006, Genes & development.

Human Immunodeficiency Virus-Associated Diarrhea: Still an Issue in the Era of Antiretroviral Therapy

M. Poles, A. Dikman, Emily A. Schonfeld, 2015, Digestive Diseases and Sciences.

795 REAL WORLD COSTS OF TELAPREVIR-BASED TRIPLE THERAPY, INCLUDING COSTS OF MANAGING ADVERSE EVENTS, AT THE MOUNT SINAI MEDICAL CENTER, NY: $147,000 PER EOT

A. Branch, V. Martel-Laferrière, D. Dieterich, 2013 .

Occupational Depression in a Spanish-Speaking Sample: Associations with Cognitive Performance and Work-Life Characteristics

R. Bianchi, I. Schonfeld, G. Manzano-García, 2022, Revista de Psicología del Trabajo y de las Organizaciones.

Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection

A. Branch, V. Martel-Laferrière, D. Dieterich, 2017, World journal of hepatology.

Geographic Areas of Liver Distribution in the United States Should Not Be Redesigned According to the 2016 Eight‐District Organ Procurement and Transplantation Network Proposal

Robert S. Brown, Emily A. Schonfeld, Jennifer Batisti, 2018, Clinical liver disease.

1137 EFFECTIVENESS OF HCV TRIPLE THERAPY WITH TELAPREVIR IN NEW YORK CITY

A. Branch, V. Martel-Laferrière, M. Vachon, 2012 .